23ANDME PARTNERS WITH STANFORD RESEARCHER ON MPN

  • MPNRF | April 28, 2021

    July 5, 2016

    Researchers at Stanford have partnered with the genetic sequencing company 23andMe to study of 726 people with PV, ET and MF, compared to a control population from the 23andMe dataset. Dr. Jason Gotlib reports in Blood that individuals found in the control without an MPN, but with the JAK2 mutation have a predisposition to developing MPN as well as JAK2 V617F clonal hematopoiesis, a more common phenomenon that may foreshadow the development of an overt neoplasm.

    http://www.bloodjournal.org/content/early/2016/06/30/blood-2015-06-652941